A

Aegirbio AB
F:52Q

Watchlist Manager
Aegirbio AB
F:52Q
Watchlist
Price: 0.1438 EUR -2.71%
Market Cap: 5.2m EUR

Wall Street
Price Targets

52Q Price Targets Summary
Aegirbio AB

There are no price targets for 52Q.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Aegirbio AB Competitors:
Price Targets
CMPX
Compass Therapeutics Inc.
144% Upside
ORKA
Oruka Therapeutics Inc
58% Upside
VCYT
Veracyte Inc
15% Upside
OPK
OPKO Health Inc
186% Upside
LGND
Ligand Pharmaceuticals Inc
26% Upside
CHRS
Coherus BioSciences Inc
338% Upside
ALKS
Alkermes Plc
57% Upside
EXEL
Exelixis Inc
1% Downside

Revenue
Forecast

Revenue Estimate
Aegirbio AB

Revenue forecast
is not available for
Aegirbio AB

Operating Income
Forecast

Operating Income Estimate
Aegirbio AB

Operating Income forecast
is not available for
Aegirbio AB

Net Income
Forecast

Net Income Estimate
Aegirbio AB

Net Income forecast
is not available for
Aegirbio AB
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 52Q's stock price target?
Not Available

52Q doesn't have any price targets made by Wall Street professionals.

Back to Top